تداخل‌های دارویی
Alogliptin-pioglitazone + Cannabidiol
شدت: متوسط
Alogliptin-pioglitazone and Cannabidiol: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Cannabidiol may inhibit CYP2C8, the main enzyme clearing pioglitazone, and could raise pioglitazone levels. This may increase the risk of fluid retention, edema, weight gain and hypoglycemia.
معنای این تداخل به زبان ساده
Alogliptin-pioglitazone and Cannabidiol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Alogliptin-pioglitazone belongs to Endocrine; Cannabidiol belongs to Central Nervous System.
چرا رخ می‌دهد
Inhibition of CYP2C8-mediated pioglitazone metabolism.
اقدام لازم
Monitor for edema, weight gain and glycemic changes when cannabidiol is started, and reduce the pioglitazone dose if adverse effects appear.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Alogliptin-pioglitazone و Cannabidiol، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Alogliptin-pioglitazone
تداخلات دیگر Cannabidiol
پرسش‌های متداول
Can I take Alogliptin-pioglitazone with Cannabidiol?
MediHelp rates the interaction as moderate. Alogliptin-pioglitazone and Cannabidiol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cannabidiol may inhibit CYP2C8, the main enzyme clearing pioglitazone, and could raise pioglitazone levels. This may increase the risk of fluid retention, edema, weight gain and hypoglycemia.
How serious is the interaction between Alogliptin-pioglitazone and Cannabidiol?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for edema, weight gain and glycemic changes when cannabidiol is started, and reduce the pioglitazone dose if adverse effects appear.
What other medicines interact with Alogliptin-pioglitazone?
MediHelp also lists interactions of Alogliptin-pioglitazone with, for example, Gemfibrozil, Insulin aspart, Insulin degludec. The full list is on the Alogliptin-pioglitazone page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
